Description
ABBOTT COVID-19 SEROLOGY TESTING SUPPLIES: ADDING CLINS EXTEND POP
Base award description: ABBOTT COVID-19 SEROLOGY TESTING SUPPLIES
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-03-26+$0= $0
- Mod P000012021-04-20+$0= $0
- Mod P000022021-09-29+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-03-26 | +$0 | $0 | ABBOTT COVID-19 SEROLOGY TESTING SUPPLIES |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-04-20 | +$0 | $0 | ABBOTT COVID-19 SEROLOGY TESTING SUPPLIES: ADDING CLINS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2021-09-29 | +$0 | $0 | ABBOTT COVID-19 SEROLOGY TESTING SUPPLIES: ADDING CLINS EXTEND POP |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6550 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X22C0007 | BECTON, DICKINSON AND COMPANY | SAC FREDERICK (36C10X) | $74,942,246 | FY2022 |
| 36C10X21N0105 | CEPHEID | SAC FREDERICK (36C10X) | $27,353,200 | FY2021 |
| 36C10X21N0103 | CEPHEID | SAC FREDERICK (36C10X) | $148,585 | FY2021 |
| 36C10X21N0086 | CEPHEID | SAC FREDERICK (36C10X) | $594,340 | FY2021 |
| 36C10X21N0066 | CEPHEID | SAC FREDERICK (36C10X) | $297,170 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C10X21D0012_3600 · retrieved 2026-09-26.